Metropolitan Life Insurance CO Caribou Biosciences, Inc. Transaction History

Metropolitan Life Insurance CO

  • $281 Million
  • Q3 2024

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$4.82 - $8.26 $776 - $1,329
161 Added 3.58%
4,652 $23,000
Q3 2023

Nov 14, 2023
BUY
$4.08 - $8.14 $4,949 - $9,873
1,213 Added 37.0%
4,491 $21,000
Q1 2023

May 15, 2023
SELL
$4.3 - $7.78 $1,522 - $2,754
-354 Reduced 9.75%
3,278 $17,000
Q4 2022

Jun 14, 2023
BUY
$5.57 - $11.01 $1,971 - $3,897
354 Added 10.8%
3,632 $22.8 Million
Q3 2022

Jun 14, 2023
BUY
$5.34 - $12.79 $1,890 - $4,527
354 Added 10.8%
3,632 $38.3 Million
Q2 2022

Jun 20, 2023
BUY
$5.1 - $9.74 $1,805 - $3,447
354 Added 10.8%
3,632 $19,000
Q1 2022

Jun 20, 2023
BUY
$8.42 - $15.32 $2,980 - $5,423
354 Added 10.8%
3,632 $33,000
Q1 2022

Mar 30, 2023
SELL
$8.42 - $15.32 $17,387 - $31,635
-2,065 Reduced 36.25%
3,632 $33,000
Q1 2022

May 12, 2022
SELL
$8.42 - $15.32 $17,387 - $31,635
-2,065 Reduced 36.25%
3,632 $33,000
Q4 2021

Jun 21, 2023
BUY
$14.59 - $23.26 $35,293 - $56,265
2,419 Added 73.79%
5,697 $85,000
Q3 2021

Jun 21, 2023
BUY
$15.75 - $30.29 $38,099 - $73,271
2,419 Added 73.79%
5,697 $135,000
Q3 2021

Mar 30, 2023
BUY
$15.75 - $30.29 $32,523 - $62,548
2,065 Added 56.86%
5,697 $135,000
Q3 2021

Nov 15, 2021
BUY
$15.75 - $30.29 $89,727 - $172,562
5,697 New
5,697 $136,000

Others Institutions Holding CRBU

# of Institutions
135
Shares Held
52.6M
Call Options Held
148K
Put Options Held
70.7K
View Full List

About Caribou Biosciences, Inc.

CRBU Quotes by TradingView
  • Ticker CRBU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,840,800
  • Market Cap $110M
  • Description
  • Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...
More about CRBU
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email